This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holt, J. A. Articles by Billin, A. N. Search for Related Content PubMed PubMed Citation Articles by Holt, J. A. Articles by Billin, A. N.

Helix 1/8 Interactions Influence the Activity of Nuclear Receptor Ligand-Binding Domains

Nuclear Receptor Discovery Research, GlaxoSmithKline Research and Development, Research Triangle Park, North Carolina 27709-3398

Address all correspondence and requests for reprints to: Andrew Billin, GlaxoSmithKline Research and Development, Research Triangle Park, North Carolina 27709-3398. E-mail: andrew.n.billin{at}gsk.com.

The ligand-binding domain (LBD) of apo-nuclear receptors in solution is thought to be a very dynamic structure with many possible conformations. Upon ligand binding, the structure is stabilized to a more rigid conformation. The dynamic stabilization assay is a LBD reassembly assay that takes advantage of the high specificity of the intramolecular interactions that comprise the ligand-bound LBD. Here, we demonstrate dynamic stabilization for the nuclear receptors peroxisome proliferator-activated receptor (PPAR) and nerve growth factor inducible (NGFIB)ß and identify residues important for stabilization of the intramolecular interactions induced by PPAR ligands. Site-directed mutagenesis studies identified residues in helices 1 and 8 required for LBD reassembly. Further, disrupting the helix 1/8 interaction in the context of the holo-LBD alters the response of the receptor in a compound-specific manner, suggesting that residues far from the ligand-binding pocket can influence the stability of the ligand-bound receptor. Thus, these results support and extend models of the apo-LBD of PPAR as a dynamic structure.

NURSA Molecule Pages Link:

Nuclear Receptors:   PPARγ  |  NGFIB

Ligands:   GW 1929  |  Rosiglitazone

This article has been cited by other articles:

				P. Carlsson, K. F. Koehler, and L. Nilsson Glucocorticoid Receptor Point Mutation V571M Facilitates Coactivator and Ligand Binding by Structural Rearrangement and Stabilization Mol. Endocrinol., August 1, 2005; 19(8): 1960 - 1977. [Abstract] [Full Text] [PDF]